Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Brainstorm Cell Therapeutics Inc. (BCLI) had Return on Equity of 24.38% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.43M |
|
-- |
|
-- |
|
$2.24M |
|
$-2.24M |
|
$-0.19M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.24M |
|
$-2.20M |
|
9.27M |
|
9.27M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$0.31M |
|
$0.23M |
|
$0.71M |
|
$1.02M |
|
$11.01M |
|
-- |
|
-- |
|
$11.01M |
|
$-9.98M |
|
$-9.98M |
|
$-9.98M |
|
11.04M |
|
| Cash Flow Statement Financials | |
$-6.97M |
|
-- |
|
$6.88M |
|
$0.37M |
|
$0.28M |
|
$-0.10M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
24.38% |
24.38% |
|
-238.16% |
|
24.38% |
|
$-0.90 |
|
$-0.75 |
|
$-0.75 |
|